Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target) (GoT)

NCT05587621 NA NOT_YET_RECRUITING

Intensive Lipid-Lowering Therapy guided by a cloud-based Software System (CLIMEDO GmbH) improves (European Society of Cardiolofgy/European Atherosclerosis Society) ESC/EAS-guideline recommended LDL-cholesterol target attainment and adherence in patients with ST-Elevation Myocardial (STEMI) and Non-ST-Elevation Myocardial Infarctions (NSTEMI).

Details

Lead sponsor	Jena University Hospital
Phase	NA
Status	NOT_YET_RECRUITING
Enrolment	300
Start date	Mon Apr 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Dec 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• ST Elevation Myocardial Infarction
• Non-ST Elevation Myocardial Infarction
• LDL-cholesterol

Interventions

• statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran

Countries

Germany